Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Overexpresses HER2 - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Overexpresses HER2

This study has been completed.

Study NCT00004883 Information provided by National Cancer Institute (NCI)

First Received: March 7, 2000 Last Updated: February 6, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Clamon G, Herndon J, Kern J, Govindan R, Garst J, Watson D, Green M; Cancer and Leukemia Group B. Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B. Cancer. 2005 Apr 15;103(8):1670-5.

Back to top of Main Content